Measurement of circulating cell-free DNA levels by a new simple fluorescent test in patients with primary colorectal cancer

American Journal of Clinical Pathology

Volumn 135, Issue 2, 2011, Pages 264-270

  Czeiger, David ^a   Shaked, Gad ^a   Eini, Hadar ^a   Vered, Ilan ^a   Belochitski, Olga ^a   Avriel, Avital ^a   Ariad, Samuel ^a   Douvdevani, Amos ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Biomarker; Carcinoembryonic antigen; Circulating cell free DNA; Colorectal cancer; Pathologic grade

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CELL FREE DNA; DNA; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; MALE; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; AGED; ANIMAL; BLOOD; COLORECTAL TUMOR; ECONOMICS; FLUOROMETRY; LABORATORY DIAGNOSIS; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DNA; FALSE POSITIVE REACTIONS; FEMALE; FLUOROMETRY; HUMANS; MALE; MASS SCREENING; MICE; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 85047687269     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP4RK2IHVKTTZV     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108. (Pubitemid 40372904)
2. Duffy MJ, van Dalen A, Haglund C, et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007;43:1348-1360. (Pubitemid 46874070)
3. Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24:5313-5327. (Pubitemid 46631379)
4. Goldstein MJ, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest. 2005;23:338-351. (Pubitemid 41656973)
5. Tan E, Gouvas N, Nicholls RJ, et al. Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surg Oncol. 2009;18:15-24.
6. Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37:646-650. (Pubitemid 8051621)
7. Gormally E, Caboux E, Vineis P, et al. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res. 2007;635:105-117. (Pubitemid 46756399)
8. Flamini E, Mercatali L, Nanni O, et al. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. Clin Cancer Res. 2006;12:6985-6988. (Pubitemid 44974493)
9. Kolesnikova EV, Tamkovich SN, Bryzgunova OE, et al. Circulating DNA in the blood of gastric cancer patients. Ann N y Acad Sci. 2008;1137:226-231.
10. Sai S, Ichikawa D, Tomita H, et al. Quantification of plasma cell-free DNA in patients with gastric cancer. Anticancer Res. 2007;27:2747-2751. (Pubitemid 47227992)
11. Schwarzenbach H, Stoehlmacher J, Pantel K, et al. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer. Ann N y Acad Sci. 2008;1137:190-196.
12. Holdenrieder S, Stieber P, Forg T, et al. Apoptosis in serum of patients with solid tumours. Anticancer Res. 1999;19:2721-2724. (Pubitemid 29392446)
13. Stroun M, Anker P, Lyautey J, et al. Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol. 1987;23:707-712. (Pubitemid 17119706)
14. Goldshtein H, Hausmann MJ, Douvdevani A. A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids. Ann Clin Biochem. 2009;46:488-494.
15. Tuma RS, Beaudet MP, Jin X, et al. Characterization of SYBR Gold nucleic acid gel stain: a dye optimized for use with 300-nm ultraviolet transilluminators. Anal Biochem. 1999;268:278-288. (Pubitemid 29147143)
16. Reddy AL, Fialkow PJ. Multicellular origin of fibrosarcomas in mice induced by the chemical carcinogen 3-methylcholanthrene. J Exp Med. 1979;150:878-887. (Pubitemid 10227335)
17. Attia MA, Weiss DW. Immunology of spontaneous mammary carcinomas in mice, V: acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus. Cancer Res. 1966;26:1787-1800.
18. Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27:3109-3116.